BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17034601)

  • 21. Practice patterns in screening and management of prostate cancer in elderly men.
    Konety BR; Sharp VJ; Verma M; Williams RD;
    Urology; 2006 Nov; 68(5):1051-6. PubMed ID: 17095076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PSA testing in office-based clinics: are we testing as much as we think?
    González HM; West B; Underwood W
    J Am Coll Surg; 2005 Dec; 201(6):906-12. PubMed ID: 16310694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Early detection of prostate cancer by PSA testing: the results of a qualitative study on barriers caused by physicians in Austria implementing informed decision making].
    Malli G
    Gesundheitswesen; 2013 Jan; 75(1):22-8. PubMed ID: 22836936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK.
    Brett J; Watson E; Hewitson P; Bukach C; Edwards A; Elwyn G; Austoker J
    BMC Fam Pract; 2005 Jun; 6(1):24. PubMed ID: 15946386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Has there been a change in practice of screening for prostate cancer with prostate-specific antigen in Ontario?
    Bunting PS
    Clin Biochem; 2004 Oct; 37(10):898-903. PubMed ID: 15369721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PSA screening in New Zealand: total population results and general practitioners' current attitudes and practices.
    van Rij S; Dowell T; Nacey J
    N Z Med J; 2013 Aug; 126(1381):27-36. PubMed ID: 24150262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What influences men's decision to have a prostate-specific antigen test? A qualitative study.
    Rai T; Clements A; Bukach C; Shine B; Austoker J; Watson E
    Fam Pract; 2007 Sep; 24(4):365-71. PubMed ID: 17644829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are doctors examining prostates in university hospital?
    Lim CH; Quinlan DM
    Urology; 2007 Nov; 70(5):843-5. PubMed ID: 18068436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of PSA requests from general practitioners received by one Dublin hospital.
    McGing PG
    Ir Med J; 1998; 91(2):61-2. PubMed ID: 9617033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variable prostate-specific antigen management patterns by nonurologist providers at a tertiary care medical center.
    Lin YK; Gettle L; Raman JD
    Urology; 2011 Aug; 78(2):244-8. PubMed ID: 21664655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic consultations in primary care: GPs' responses to three scenarios.
    McCann S; MacAuley D; Barnett Y
    Scand J Prim Health Care; 2005 Jun; 23(2):109-14. PubMed ID: 16036550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dissemination of evidence-based information about PSA test and prostatic cancer to physicians].
    Norderhaug IN; Wisløff T; Fosså S; Sandberg S; Malde K; Forland F; Førde OH
    Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2893-5. PubMed ID: 15550959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shared care and the management of lower urinary tract symptoms.
    Wolters R; Wensing M; Klomp M; van Weel C; Grol R
    BJU Int; 2004 Dec; 94(9):1287-90. PubMed ID: 15610107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of prostate-specific antigen testing].
    Mukai TO; Bro F; Pedersen KV; Vedsted P
    Ugeskr Laeger; 2010 Mar; 172(9):696-700. PubMed ID: 20199746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intention to test for prostate cancer.
    Berglund G; Nilsson S; Nordin K
    Eur J Cancer; 2005 May; 41(7):990-7. PubMed ID: 15862747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PCA3 urine mRNA testing for prostate carcinoma: patterns of use by community urologists and assay performance in reference laboratory setting.
    Shappell SB; Fulmer J; Arguello D; Wright BS; Oppenheimer JR; Putzi MJ
    Urology; 2009 Feb; 73(2):363-8. PubMed ID: 18995890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices.
    Shephard MD; Mazzachi BC; Watkinson L; Shephard AK; Laurence C; Gialamas A; Bubner T
    Rural Remote Health; 2009; 9(3):1189. PubMed ID: 19689171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
    Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
    Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PSA screening: determinants of primary-care physician practice patterns.
    Tasian GE; Cooperberg MR; Potter MB; Cowan JE; Greene KL; Carroll PR; Chan JM
    Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):189-94. PubMed ID: 22343837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate cancer screening practices and beliefs.
    Voss JD; Schectman JM
    J Gen Intern Med; 2001 Dec; 16(12):831-7. PubMed ID: 11903762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.